SK biopharmaceuticals Co., Ltd.

326030 KRX Industrials Industrials
KOSPI
₩79,400.00
-4.80%
Delayed · cached 15 min

Fair value analysis

326030
SK biopharmaceuticals Co., Ltd.
Industrials›Industrials
₩79,400.00
Close used for this calculation
₩52,606.21Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
68/100
Profitability25/25
Returns12/25
Balance Sheet21/25
Efficiency10/25
Growth12/25
Strong
Quality radar
68Prof.25/25Ret.12/25Eff.10/25B.Sht21/25Growth12/25

Consensus fair value

₩52,606.21
Above FV
▼ -33.7% against the close used
Model range ₩28,215.28 – ₩102,270.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩28,215.28Fair value₩52,606.21Bull₩102,270.00
FairClose
52-week traded range
52W low ₩74,600.0052W high ₩140,700.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

SK biopharmaceuticals Co., Ltd. closed at ₩79,400.00, 50.9% above the consensus fair value of ₩52,606.21 drawn from 8 valuation models.

Financial DNA score 68/100 — Strong. P/E of 23.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩45,272.13
-43.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩28,215.28
-64.5%
√(22.5 × EPS × BVPS)
EPS=3409, BVPS=10379.08 · outside Graham range (P/E 23.3, P/B 7.7) — asset-light, treat as a rough floor
P/E Fair Value
₩68,180.00
-14.1%
EPS × 20x (sector P/E)
EPS=3409, Sector P/E=20x
Peter Lynch (PEG)
₩102,270.00
+28.8%
EPS × Growth% (PEG = 1 is fair)
EPS=3409, g=30%
EV/EBITDA
₩49,413.16
-37.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=203.94B
Book Value (P/B)
₩69,617.71
-12.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=10379.08, ROE=32.8%, g=6%, r=10%
Reverse DCF
₩79,400.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 9.2% | Historical: 40.6%
Margin of Safety
₩35,416.85
-55.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=47222.47, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.